ElliottRichelsonMD
Psychiatry • Jacksonville Beach, FLProfessor (Emeritus), Psychiatry and Pharmacology, Mayo Clinic School of Medicine
Dr. Richelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 Marsh Landing Pkwy
Ste 112
Jacksonville Beach, FL 32250Phone+1 904-456-0002Fax+1 904-373-0894
Summary
- Dr. Elliott Richelson is a psychiatrist based in Jacksonville Beach, FL, with a medical degree from Johns Hopkins University School of Medicine. He completed his psychiatric residency at Johns Hopkins University and his internship in internal medicine at the Washington University/B-JH/SLCH Consortium. Dr. Richelson currently serves as the Regional Medical Director for Optum Care Solutions Division of Optum Behavioral Care. His past roles include staff positions at Mayo Clinic Florida, where he is emeritus Professor of Psychiatry and of Pharmacology. He has in affective disorders, schizophrenia, and obsessive-compulsive disorder. He has authored many publications, including works focusing on antidepressants, antipsychotics, psychedelic drugs, and neurotensin's role in mental disorders.
Education & Training
Johns Hopkins UniversityResidency, Psychiatry, 1972 - 1975
Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1969 - 1970- Johns Hopkins University School of MedicineClass of 1969
Certifications & Licensure
NY State Medical License 2021 - 2027
CA State Medical License 2020 - 2026
FL State Medical License 1989 - 2026
GA State Medical License 2021 - 2026
IL State Medical License 2020 - 2026
VA State Medical License 2021 - 2026
MA State Medical License 2021 - 2026
American Board of Psychiatry and Neurology Psychiatry- Join now to see all
Publications & Presentations
PubMed
- 18 citationsThe prescriber's guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression.Vincent Van den Eynde, Wegdan R Abdelmoemin, Magid M Abraham, Jay D Amsterdam, Ian M Anderson
CNS Spectrums. 2023-08-01 - 6 citationsPsychedelic drugs for psychiatric disorders.Sabrina Correa da Costa, Tyler Oesterle, Teresa A Rummans, Elliot Richelson, Mark Gold
Journal of the Neurological Sciences. 2022-09-15 - 5 citationsA neurotensin analog blocks cocaine-conditioned place preference and reinstatement.Mona Boules, Rebecca Netz, Paul A. Fredrickson, Elliott Richelson
Behavioural Pharmacology. 2016-04-01
Grant Support
- Nt69l: A Potential, Novel Antischizophrenic DrugNational Institute Of Mental Health2006–2009
- Brain As Target For Antisense Peptide Nucleic Acid DrugsNational Institute Of Mental Health1999–2001
- Psychotropic Drugs And Receptor Sensitivity ChangesNational Institute Of Mental Health1985–1997
- Ethanol Tolerance And Dependence In VitroNational Institute On Alcohol Abuse And Alcoholism1985–1988
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
